Clinical Trial Update: Effect of Maolactin on Gastrointestinal Tract (GIT) Health [Phase 3]

View source ↗

Summary

Maolactin was studied in a Phase 3 trial for gastrointestinal dysfunction, and the trial has completed. No results are provided in this document.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Dysfunction

Drugs mentioned

• Maolactin

Snippet

Sponsor: RDC Clinical Pty Ltd | Conditions: Gastrointestinal Dysfunction | Phase 3 | Status: COMPLETED